跳至主要内容
临床试验/NCT05309239
NCT05309239Unknown不适用

Role of ROX Index as an Indicator for Non-invasive Ventilation in Acute Respiratory Failure

Assiut University1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2022年3月21日最近更新:
适应症

试验速览

阶段
不适用
入组人数
100
试验地点
1
主要终点
Success vs failure of non invasive ventilation

研究概览

简要总结

evaluation of ROX index among ICU patients to evaluate the success of non invasive ventilation or the need for intubation

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Participants admitted to RICU with type I and type II respiratory failure requiring NIV support with one or more of the following :
  • PaO2/FiO2 less than or equal to 300 mmHg despite supplying oxygen at a flow rate ≥ to 10 l/min for ≥ 15 min
  • Patients requiring ventilatory support due to increased respiratory rate ≥ 25 breaths/min or using accessory muscles of respiration

排除标准

  • Absolute indication for intubation like coma, hemodynamic instability, or life-threatening arrhythmia.
  • Contraindication to NIV like untreated pneumothorax, pneumothorax with air leak, widespread facial burn or trauma, tracheotomy,or active upper gastrointestinal bleeding.
  • Resusal to participate in the study

结局指标

主要结局

Success vs failure of non invasive ventilation

时间窗: within 6 months

by ROX index calculation

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kholoud Zakaria

Kholoud Zakaria

Assiut University

研究点 (1)

Loading locations...

相似试验

ROX Index in Acute Respiratory Failure | 临床试验